Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: A potential mechanism for direct presentation

Virology

Volumn 359, Issue 2, 2007, Pages 349-361

  Yates, Nicole L ^a   Alexander Miller, Martha A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presentation; Cell activation; Dendritic cells; Viral

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; BETA INTERFERON; CD40 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 12P40; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DENDRITIC CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; UP-REGULATION; VACCINIA VIRUS;

MURINAE; MUS; VACCINIA VIRUS;

EID: 33847042792     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.09.020     Document Type: Article

References (71)

1. Ahmed M., McKenzie M.O., Puckett S., Hojnacki M., Poliquin L., and Lyles D.S. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J. Virol. 77 (2003) 4646-4657
2. Akira S., Hoshino K., and Kaisho T. The role of Toll-like receptors and MyD88 in innate immune responses. J. Endotoxin Res. 6 (2000) 383-387
3. Alcami A., and Smith G.L. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J. Virol. 69 (1995) 4633-4639
4. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C., Vicari A., O'Garra A., Biron C., Briere F., and Trinchieri G. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2 (2001) 1144-1150
5. Baeuerle P.A., and Henkel T. Function and activation of Nf-Kappa-B in the immune-system. Annu. Rev. Immunol. 12 (1994) 141-179
6. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
7. Bartlett N., Symons J.A., Tscharke D.C., and Smith G.L. The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J. Gen. Virol. 83 (2002) 1965-1976
8. + T cells. J. Immunol. 168 (2002) 5403-5408
9. Beattie E., Tartaglia J., and Paoletti E. Vaccinia virus-encoded eIF-2 alpha homolog abrogates the antiviral effect of interferon. Virology 183 (1991) 419-422
10. Belz G.T., Smith C.M., Eichner D., Shortman K., Karupiah G., Carbone F.R., and Heath W.R. Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172 (2004) 1996-2000
11. Bieback K., Lien E., Klagge I.M., Avota E., Schneider-Schaulies J., Duprex W.P., Wagner H., Kirschning C.J., Ter M.V., and Schneider-Schaulies S. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J. Virol. 76 (2002) 8729-8736
12. Bowie A., Kiss-Toth E., Symons J.A., Smith G.L., Dower S.K., and O'Neill L.A.J. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10162-10167
13. Caux C., Massacrier C., Vanbervliet B., Dubois B., Van Kooten C., Durand I., and Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180 (1994) 1263-1272
14. Chang H.W., Watson J.C., and Jacobs B.L. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A 89 (1992) 4825-4829
15. Colamonici O.R., Domanski P., Sweitzer S.M., Larner A., and Buller R.M. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J. Biol. Chem. 270 (1995) 15974-15978
16. Cumberbatch M., and Kimber I. Dermal Tumor-Necrosis-Factor-Alpha induces dendritic cell-migration to draining lymph-nodes, and possibly provides one stimulus for Langerhans cell-migration. Immunology 75 (1992) 257-263
17. Cumberbatch M., Illingworth I., and Kimber I. Antigen-bearing dendritic cells in the draining lymph-nodes of contact sensitized mice-cluster formation with lymphocytes. Immunology 74 (1991) 139-145
18. + T cells. J. Immunol. 162 (1999) 3256-3262
19. Curtsinger J.M., Lins D.C., and Mescher M.F. Signal 3 determines tolerance versus full activation of naïve CD8 T cells: dissociating proliferation and development of effector function. J. Exp. Med. 197 (2003) 1141-1151
20. Curtsinger J.M., Valenzuela J.O., Agarwal P., Lins D., and Mescher M.F. Cutting edge: type IIFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174 (2005) 4465-4469
21. DiPerna G., Stack J., Bowie A.G., Boyd A., Kotwal G., Zhang Z.N., Arvikar S., Latz E., Fitzgerald K.A., and Marshall W.L. Poxvirus protein N1L targets the I-kappa B kinase complex, inhibits signaling to NF-kappa B by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappa B and IRF3 signaling by Toll-like receptors. J. Biol. Chem. 279 (2004) 36570-36578
22. Drillien R., Spehner D., Bohbot A., and Hanau D. Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology 268 (2000) 471-481
23. Drillien R., Spehner D., and Hanau D. Modified vaccinia virus Ankara induces moderate activation of human dendritic cells. J. Gen. Virol. 85 (2004) 2167-2175
24. Earl P.L., Koenig S., and Moss B. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65 (1991) 31-41
25. Engelmayer J., Larsson M., Subklewe M., Chahroudi A., Cox W.I., Steinman R.M., and Bhardwaj N. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163 (1999) 6762-6768
26. Facchetti F., Dewolfpeeters C., Mason D.Y., Pulford K., Vandenoord J.J., and Desmet V.J. Plasmacytoid T-cells-immunohistochemical evidence for their monocyte macrophage origin. Am. J. Pathol. 133 (1988) 15-21
27. Freeman G.J., Borriello F., Hodes R.J., Reiser H., Hathcock K.S., Laszlo G., Mcknight A.J., Kim J., Du L.N., Lombard D.B., Gray G.S., Nadler L.M., and Sharpe A.H. Uncovering of functional alternative Ctla-4 counter-receptor in B7-deficient mice. Science 262 (1993) 907-909
28. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177 (1993) 1791-1796
29. Harding F.A., McArthur J.G., Gross J.A., Raulet D.H., and Allison J.P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356 (1992) 607-609
30. Harte M.T., Haga I.R., Maloney G., Gray P., Reading P.C., Bartlett N.W., Smith G.L., Bowie A., and O'Neill L.A.J. The poxvirus protein A52R targets toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197 (2003) 343-351
31. Henderson D.A. Eradication of smallpox. Sci. Am. 235 (1976) 25-33
32. Henderson D.A., Inglesby T.V., Bartlett J.G., Ascher M.S., Eitzen E., Jahrling P.B., Hauer J., Layton M., McDade J., Osterholm M.T., O'Toole T., Parker G., Perl T., Russell P.K., and Tonat K. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281 (1999) 2127-2137
33. Hotta C., Fujimaki H., Yoshinari M., Nakazawa M., and Minami M. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells. Immunology 117 (2006) 97-107
34. Howard S.T., Chan Y.S., and Smith G.L. Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family. Virology 180 (1991) 633-647
35. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., and Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176 (1992) 1693-1702
36. Kieny M.P., Lathe R., Drillien R., Spehner D., Skory S., Schmitt D., Wiktor T., Koprowski H., and Lecocq J.P. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 312 (1984) 163-166
37. Koszinowski U., and Thomssen R. Target cell-dependent T-cell-mediated lysis of vaccinia virus-infected cells. Eur. J. Immunol. 5 (1975) 245-251
38. Krug A., Veeraswamy R., Pekosz A., Kanagawa O., Unanue E.R., Colonna M., and Cella M. Interferon-producing cells fail to induce proliferation of naïve T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J. Exp. Med. 197 (2003) 899-906
39. Kukutsch N.A., Rossner S., Austyn J.M., Schuler G., and Lutz M.B. Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells. J. Invest. Dermatol. 115 (2000) 449-453
40. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., and Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1 (2000) 398-401
41. Li J., Schuler-Thurner B., Schuler G., Huber C., and Seliger B. Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation. Int. Immunol. 13 (2001) 1515-1523
42. Luft T., Pang K.C., Thomas E., Hertzog P., Hart D.N., Trapani J., and Cebon J. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161 (1998) 1947-1953
43. Lyles D.S., McKenzie M.O., Ahmed M., and Woolwine S.C. Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression. Virology 225 (1996) 172-180
44. MacAry P.A., Lindsay M., Scott M.A., Craig J.I., Luzio J.P., and Lehner P.J. Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells. Proc. Natl. Acad. Sci. U.S.A 98 (2001) 3982-3987
45. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev., Immunol. 1 (2001) 135-145
46. Montoya M., Schiavoni G., Mattei F., Gresser I., Belardelli F., Borrow P., and Tough D.F. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99 (2002) 3263-3271
47. Mossman K., Upton C., Buller R.M., and McFadden G. Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology 208 (1995) 762-769
48. Nakano H., Yanagita M., and Gunn M.D. CD11c+B220+Gr-1+ cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194 (2001) 1171-1178
49. + T cells by infected dendritic cells in vivo. Nat. Immunol. 3 (2002) 265-271
50. Paez E., and Esteban M. Nature and mode of action of vaccinia virus products that block activation of the Interferon-mediated Ppp(A2(P)Na-synthetase. Virology 134 (1984) 29-39
51. Paoletti E. Applications of pox virus vectors to vaccination: an update. Proc. Natl. Acad. Sci. U.S.A 93 (1996) 11349-11353
52. Rassa J.C., Meyers J.L., Zhang Y.M., Kudaravalli R., and Ross S.R. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 2281-2286
53. Rizzitelli A., Vremec D., Villadangos J.A., Mavaddat N., Wright M.D., and Shortman K. Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand. Eur J. Immunol. 35 (2005) 3209-3220
54. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble-antigen by cultured human dendritic cells is maintained by granulocyte-macrophage colony-stimulating factor plus interleukin-4 and down-regulated by tumor-necrosis-factor-alpha. J. Exp. Med. 179 (1994) 1109-1118
55. + T-cell responses in vivo after viral stimulation. Blood 104 (2004) 1808-1815
56. + T cells in vivo. J. Immunol. 163 (1999) 2561-2567
57. + T cells requires a third signal that can be provided by IL-12. J. Immunol. 168 (2002) 5521-5529
58. Sen R., and Baltimore D. Inducibility of kappa-immunoglobulin enhancer-binding protein Nf-Kappa-B by a posttranslational mechanism. Cell 47 (1986) 921-928
59. Sen R., and Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46 (1986) 705-716
60. + CTL following exposure to vaccinia virus via different routes. J. Immunol. 169 (2002) 4222-4229
61. Shisler J.L., and Jin X.L. The vaccinia virus K1L gene product inhibits host NF-kappa B activation by preventing I kappa B alpha degradation. J. Virol. 78 (2004) 3553-3560
62. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., and Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science 284 (1999) 1835-1837
63. Smith G.L., and Chan Y.S. 2 vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. J. Gen. Virol. 72 (1991) 511-518
64. Smith S.A., and Kotwal G.J. Immune response to poxvirus infections in various animals. Crit. Rev. Microbiol. 28 (2002) 149-185
65. Stack J., Haga I.R., Schroder M., Bartlett N.W., Maloney G., Reading P.C., Fitzgerald K.A., Smith G.L., and Bowie A.G. Vaccinia virus protein Toll-like-interleukin-1 A46R targets multiple receptor adaptors and contributes to virulence. J. Exp. Med. 201 (2005) 1007-1018
66. Symons J.A., Alcami A., and Smith G.L. Vaccinia virus encodes a soluble Type-I interferon receptor of novel structure and broad species-specificity. Cell 81 (1995) 551-560
67. Upton C., Macen J.L., Schreiber M., and McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184 (1991) 370-382
68. Wesa A.K., and Galy A. IL-1 beta induces dendritic cells to produce IL-12. Int. Immunol. 13 (2001) 1053-1061
69. Whitton J.L., Sheng N., Oldstone M.B., and McKee T.A. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67 (1993) 348-352
70. Wilson N.S., Behrens G.M., Lundie R.J., Smith C.M., Waithman J., Young L., Forehan S.P., Mount A., Steptoe R.J., Shortman K.D., Koning-Ward T.F., Belz G.T., Carbone F.R., Crabb B.S., Heath W.R., and Villadangos J.A. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7 (2006) 165-172
71. Xiang Y., Condit R.C., Vijaysri S., Jacobs B., Williams B.R.G., and Silverman R.H. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. J. Virol. 76 (2002) 5251-5259